Summarized by Masters of Longevity from Longevity Technology.
A clear-eyed explainer of an interactive market-model article that lets readers test how assumptions shape forecasts for longevity biotech.
Key Takeaways
- The $617 billion TAM is a conditional model based on assumptions about eligibility, pricing, adoption, and timing.
- The public TAM Explorer lets users change variables to see how different assumptions materially alter the projected market size.
